This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Belinda Gaston
Associate Vice President
Contact
BelindaGaston@westat.comOverview
Belinda Gaston, MPH, is an Associate Vice President for Public Health. Gaston has 20+ years of expertise in strategic communications, public health partnerships, and technical assistance. She serves as project director for the Centers for Disease Control and Prevention’s (CDC’s) HIV Communications and Partnerships as well as the Prevention Research Translation Branch’s communications support projects. She is also senior advisor to CDC’s National Prevention Information Network health education and communications project. Previously, Gaston led the development and implementation of CDC’s childhood immunization campaign, the Business Responds to AIDS program, and the cytomegalovirus (CMV) awareness initiative.
In addition to her work at Westat, Gaston has partnered to form Comms Noire, a community of Black health communications and social marketing professionals dedicated to creating messages that impact society for good. It provides members with a community, access to resources, and opportunities for leadership development.
Education
- MPH, Epidemiology, University of Alabama at Birmingham School of Public Health
- BA, English, Emory University
-
Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease
37,
Neoplasia
January 2023
E. Marshall, N. Joshi, J. Crowley, S. McCormack, S. Cheng, W. Faig, P.B. Storm, et al.
DOILink for: Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease -
Perspective
Experts Discuss Progress to End HIV During COVID YearsJanuary 2022
The COVID pandemic has highlighted existing public health problems founded in inequitable access to quality health care. A larger audience is now aware of the…
-
Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV
225,
Journal of Infectious Diseases
January 2022
G. Duarte, P. Muresan, S. Ward, L. Laimon, S.I. Pelton, J. Canniff, A. Golner, et al.
DOILink for: Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV